Cargando…
Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
BACKGROUND: The dismal overall survival (OS) prognosis of glioblastoma, even after trimodal therapy, can be attributed mainly to the frequent incidence of intracranial relapse (ICR), which tends to present as an in-field recurrence after a radiation dose of 60 Gray (Gy). In this study, molecular mar...
Autores principales: | Zschaeck, Sebastian, Wust, Peter, Graf, Reinhold, Misch, Martin, Onken, Julia, Ghadjar, Pirus, Badakhshi, Harun, Florange, Julian, Budach, Volker, Kaul, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299982/ https://www.ncbi.nlm.nih.gov/pubmed/30567592 http://dx.doi.org/10.1186/s13014-018-1194-8 |
Ejemplares similares
-
Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016) -
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
por: Hemmati, Saman Moritz, et al.
Publicado: (2019) -
Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
por: Badakhshi, Harun, et al.
Publicado: (2018) -
Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017) -
Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)